IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding IO Biotech, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 21 | 17 | −4 |
| Shares | 15.3M | 14.3M | −1.05M (−6.9%) |
| Value | $41.6M | $32.8M | −$8.71M (−21.0%) |
New holders (0)
Institutions that held IO Biotech, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (4)
Institutions that held IO Biotech, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Soleus Capital Management, L.P. | 288,119 | $781.0K |
| Victory Capital Management Inc | 43,741 | $119.0K |
| Citadel Advisors LLC | 42,180 | $114.0K |
| State of Wyoming | 28 | $0 |